Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label, Multicenter, Rollover Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease
INTERVENTIONAL
Inicio: 26 de ene de 2021
ID: NCT04374253
Completado
ClinicalTrials.gov
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
OBSERVATIONAL
Inicio: 1 de nov de 2007
ID: NCT00702065
Completado
ClinicalTrials.gov
AMPLATZER™ LAA Occluder Post Approval Study
OBSERVATIONAL
Inicio: 8 de dic de 2016
ID: NCT02964208
Completado
Fase 2
ClinicalTrials.gov
A 24-week, Dose-ranging, Multicenter, Double-blind, Double-dummy, Active-controlled Core Study to Evaluate Canakinumab for Prophylaxis of Signs and Symptoms of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy and a 24-week Open-label, Multicenter Extension Study to Assess Safety, Tolerability and Efficacy of Canakinumab in Patients With Gout Who Are Given Canakinumab at the Time of Gout Flare
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00819585
Completado
ClinicalTrials.gov
Learning Mindfulness Based Practices, Empathy and Pro-social Behavior in the Educational Field: Its Influence on Health and Interpersonal Relationships
INTERVENTIONAL
Inicio: 20 de mar de 2017
ID: NCT04177017
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of Rebif New Formulation (44 Microgram [Mcg] Three Times Weekly [Tiw] and 44 Mcg Once Weekly [ow]) in Subjects at High Risk of Converting to Multiple Sclerosis (REFLEX)
INTERVENTIONAL
Inicio: 1 de nov de 2006
ID: NCT00404352
Terminado
Fase 3
ClinicalTrials.gov
A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease
INTERVENTIONAL
Inicio: 26 de abr de 2016
ID: NCT02586909
Reclutando
Fase 3
ClinicalTrials.gov
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease
INTERVENTIONAL
Inicio: 22 de nov de 2024
ID: NCT06647498
Desconocido
ClinicalTrials.gov
The Acute Optic Neuritis Network (ACON): a Non-interventional Prospective Multicenter Study on Diagnosis and Treatment of Acute Optic Neuritis
OBSERVATIONAL
Inicio: 15 de ago de 2020
ID: NCT05605951
Completado
ClinicalTrials.gov
Analysis of Brain Responses and Habituation to Multimodal Sensory Stimuli in Patients With Fibromyalgia
OBSERVATIONAL
Inicio: 14 de mar de 2025
ID: NCT06905171
Completado
ClinicalTrials.gov
Survey on Predictors of Discharge from Stroke Units in Argentina
OBSERVATIONAL
Inicio: 15 de nov de 2024
ID: NCT06623253
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00605683
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Patients With Moderate-to-Severe Dementia of the Alzheimer's Type
INTERVENTIONAL
Inicio: 1 de jun de 2005
ID: NCT00322153
Aún no recluta
ClinicalTrials.gov
Development and Validation of an Obstetric Organ Dysfunction Score to Predict Mortality in Intensive Care Unit: A Multicenter, Prospective, Cohort Study
OBSERVATIONAL
Inicio: 1 de ago de 2025
ID: NCT07068022
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CNP520 in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (AD).
INTERVENTIONAL
Inicio: 3 de ago de 2017
ID: NCT03131453
Completado
Fase 3
ClinicalTrials.gov
An Open-label Trial With TMC278 25 mg q.d. in Combination With a Background Regimen Containing 2 N(t)RTI's in HIV-1 Infected Subjects Who Participated in TMC278 Clinical Trials and Were Still Benefitting From Treatment With TMC278
INTERVENTIONAL
Inicio: 1 de feb de 2011
ID: NCT01266902
Completado
ClinicalTrials.gov
Effect of Sodium Intake in Multiple Sclerosis Disease Activity
OBSERVATIONAL
Inicio: 1 de nov de 2010
ID: NCT01846234
Reclutando
Fase 3
ClinicalTrials.gov
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 23 de sept de 2022
ID: NCT05327114
Reclutando
ClinicalTrials.gov
Music to Prevent Delirium: A Prospective, Randomized, Controlled, Three-Arm Parallel-Group Clinical Trial in an Argentine Intensive Care Unit
INTERVENTIONAL
Inicio: 2 de feb de 2026
ID: NCT07369258
Por invitación
Fase 2
ClinicalTrials.gov
An Open-Label Extension Study to Assess Long-term Safety and Tolerability of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 28 de ago de 2025
ID: NCT07188844
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros